Axis Group Ltd (AXG) is a young and dynamic middle-sized independent Contract Research Organization (CRO) focused on clinical trials.

AXG was founded in 2005 by a team of medical & pharmaceutical professionals who had broad experience in phase II–IV clinical trials. Our company has developed a number of close contacts with leading clinics, hospitals and laboratories as well as with health authorities in Ukraine. So we provide access to well-trained and motivated investigators who can enroll large numbers of treatment-naive patients in global clinical trials.

AXG has experience in oncology, pulmonology, cardiology, vascular surgery, hematology and psychiatry studies. Currently we have 25 ongoing and 4 completed clinical trials with successful audits and Sponsor awards.

AXG staff has experience in all major indications in clinical phases II–IV.

Nowadays, AXG staff has significantly developed – 16 CRAs, 5 CTAs, 1 Line Manager and 2 LPMs.

AXG staff has experience in all major indications in clinical phases II–IV. Employees of our team are physicians with good relations to their colleagues in Universities and Hospitals.

Staff is being hand-picked and thoroughly trained: AXG offers its employees a diverse range of training courses and mentoring. 

Director – Oleksandra Razina

Line Manager – Kateryna Potapova

Local Project Manager – Sergiy Shylov

Local Project Manager – Daria Rudenko

Regulatory Manager – Ievgen Grushevenko

AXG  mission is to be No 1 local CRO based on consistent quality and execution in Ukraine and other countries such as Georgia, Kazakhstan and Russia.  

We provide high quality services which go along with competitive prices.

The key focus of the company is to provide innovative solutions to enhance patient’s recruitment and ensure high quality of collected clinical data. In all studies managed by AXG we have 90% recruitment rate or over-recruitment.

We also review thoroughly planned and ongoing clinical research processes identifying contingencies and proposing effective solutions to ensure smooth progress of the project and to select the most cost-effective approach. Our organization is designed  to achieve maximum  flexibility reflecting changing research environment and to promote innovative processes which should result in the shortening of trial start-up due to fast feasibility collection and completion of the study. For experience in feasibility, please, see AXG presentation.

AXG maintains own corporate Standard Operating Procedures (SOPs) which govern all critical operations in trial management, data management, biostatistics, and clinical research report writing. These SOPs comply with all industry regulations set by TPD, FDA and ICH. Project-specific SOPs are generated as required.

A contract research organization, also called a clinical research organization, (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services (for both drugs and medical devices). CROs range from large, international full service organizations to small, niche specialty groups and can offer their clients the experience of moving a new drug or device from its conception to FDA/EMA marketing approval without the drug sponsor having to maintain a staff for these services.